Reply to Paul and Leibovici
- PMID: 29240925
- DOI: 10.1093/infdis/jix537
Reply to Paul and Leibovici
Comment on
-
Drug Development for Multidrug-Resistant Bacteria: Why Compromise?J Infect Dis. 2018 Jan 17;217(3):508-509. doi: 10.1093/infdis/jix536. J Infect Dis. 2018. PMID: 29240890 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical